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a b s t r a c t
Introduction: Hepatitis B virus (HBV) infection is an important worldwide public health prob-
lem. In Brazil, the Ministry of Health estimates that 15% of the population has had contact
with HBV, and that the mean rate of chronic carriers in Northeastern Brazil is around 0.5%.
Objective: The aim of this study was to assess the prevalence of HBV markers in pregnant
women receiving prenatal care at the public maternity hospitals of São Luís.
Methods: Demographical and epidemiological datawere collected from541 pregnantwomen
according to the research protocol. Blood samples were collected, and the anti-HBc test was
performed ﬁrst. If positive, the sample was subsequently tested for HBsAg and anti-HBs. All
HBsAg and/or anti-HBc positive samples were additionally tested for HBV-DNA.
Results: 40 (7.4%) pregnantwomen turned out positive for anti-HBc. Of those, ﬁve (0.9%)were
HBsAg positive, four (0.7%) were anti-HBc positive with negative HBsAg and anti-HBs, and
31 (5.7%) were positive for anti-HBc and anti-HBs. Anti-HBc positivity was associated with
family history of hepatitis and education level below 11 years of schooling. HBV-DNA was
positive in only oneHBsAg-positive sample. Therewas noHBV-DNApositivity amongHBsAgnegative samples.
Conclusions: The prevalence of HBsAg in pregnant women in this study conﬁrmed that São
Luís is a low endemicity area. Occult hepatitis B was not detected in these samples.
and low endemicity (less than 2%). In Brazil, prevalence rates
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Table 1 – Marital status and years of education of study
pregnant women assisted in public maternities – São
Luís, MA, Brazil, 2009.







> 17 07 (1.5%)
Marital status (n = 540)
Single 89 (16.5%)
Concerning exposure to potential risk factors forHBV infec-
tion, 168 (31%) hadbeenhospitalized at some timeduring their
lives, 17 (3%) had received blood transfusions, 120 (22%) had
Table 2 – Exposure to potential risk factors for hepatitis B
infection, in pregnant women assisted in public
maternities – São Luís, MA, Brazil, 2009.
Dental treatment 205 38%
Surgery 120 22%
Hospitalization 168 31%
Family history of hepatitis 120 22%518 braz j infect d
The Brazilian Ministry of Health estimates that 15% of the
country population has been exposed to HBV, and that the
average rate of chronic carriers in the capital cities of North-
east Brazil is approximately 0.5%, according to a national
survey.4 HBV is transmitted by perinatal, parenteral, and sex-
ual exposures.5,6 Perinatal transmission is of great importance
in the epidemiology of the disease, since only 5% to 10%
of those who acquire the infection in adulthood progress to
chronicity. In contrast, children born to HBV infected mothers
have a risk of chronicity of up to 90%.1,7
Cross-sectional studies have been performed in order to
estimate the prevalence of this chronic infection among
pregnant women in Brazil.8–12 Depending on the region stud-
ied, results have varied from 0.5% to 8.7%.
Although chronic HBV infection is deﬁned as the presence
of HBV surface antigen (HBsAg) for more than six months,1
recently a form of chronic infection has been described in
which the HBV-DNA is detected in the serum or liver tissue of
patients with negative HBsAg, which is known as occult hep-
atitis B.13,14 Populations from high endemicity regions appear
to have higher prevalence of occult HBV infection; however, it
has also been detected in speciﬁc populations of Brazil.15,16
In pregnant women, there is little information about occult
HBV infection,17,18 and it is still not well established whether
prophylactic actions are needed to prevent infection in new-
born children.
There are no data about the prevalence of hepatitis B
among pregnant women in the state of Maranhão; also, there
have been no studies on occult hepatitis B in pregnant women
in any state of Brazil. Thus, this study aimed to estimate the
prevalence of hepatitis B infection markers among pregnant
women assisted at the public hospitals of São Luís, the capital
city of Maranhão state, including investigation of HBV occult
infection.
Material and methods
The sample size (n=500) was calculated on the basis of the
total number of ﬁrst visits during antenatal care in four public
maternity hospitals of São Luís in 2007, which was 17,296, and
the estimated HBsAg prevalence of 0.5% in the general popu-
lation of Northeast Brazil.4 An absolute precision of 0.05 and
a conﬁdence level of 95% were also considered.
Data, as well as by blood collection Data from consecu-
tive pregnant women receiving antenatal care in the selected
maternity hospitals, between January and July 2009, were col-
lected by completing a research form (including age, marital
status, education level, and risk factors). Additionally, blood
was taken for molecular and serological tests.
Serologic tests were performed with the LIAISON kit (Dia-
Sorin), using the chemiluminescence technique and following
the procedures established by the manufacturer. First, sero-
logic tests for total anti-HBc (marker of contact with HBV)
were performed. If it turned out positive HBsAg and anti-
HBs were subsequently performed. Positive HBsAg individuals
were retested six months later.
All positive total anti-HBc and negative HBsAg sera, irre-
spective of the presence of anti-HBs, were tested for HBV-DNA
by polymerase chain reaction (PCR). Extraction of viral DNAMarried 123 (23%)
Consensual union 328 (61.5%)
was performed using the QIAamp DNA Kit Qiagen (Ger-
many), according to the manufacturer’s instructions. The S
gene region of HBV was ampliﬁed with previously described
primers.19
Chronic HBV carriers were deﬁned as pregnant women
with positive total anti-HBc and HBsAg, longer than six
months. Those with positive total anti-HBc and anti-HBs were
considered as immune to HBV infection, and those with pos-
itive anti-HBc, negative HBsAg and positive HBV-DNA were
considered as occult HBV infection carriers.
Numeric variables were presented as means and standard
deviations, and the categorical variables as n and percent-
age (%), with 95% conﬁdence intervals. Differences between
numerical variables were tested by Student’s t-test, and
between categorical variables by the Chi-squared test. p-
values<0.05 were considered statistically signiﬁcant.
The study was performed according to ethical guidelines
and was approved by the Ethics Committee in Research of the
University Hospital of the Universidade Federal do Maranhão.
Only pregnant women who signed the informed consent were
included in this study.
Results
541 pregnant women participated in this study. The mean age
was 24± 5 years. Three hundred and sixteen (59%) reported
having 11 or more years of schooling. 327 (61%) lived in a
consensual union (Table 1).More than one sexual partner 106 20%
Blood transfusion 17 03%
Use of injectable illicit drugs 01 0.2%
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Table 3 – Comparison between pregnant women with and without positive serological markers of hepatitis B in public
maternities of São Luís, MA, Brazil, 2009.
Anti-HBc (+)(n=40) Anti-HBc (-)(n = 501) p
Age (mean±SD) 26± 6 24± 5 0.086
Less than 11 years of schooling 23 (57%) 202 (40%) 0.036
Dental treatment 12 (30%) 193 (38%) 0.185
Surgery 10 (25%) 110 (22%) 0.391
Family history of hepatitis 15 (39%) 105 (21%) 0.011
Hospitalization 16 (41%) 152 (30%) 0.115







































bBlood transfusion 0 (0.0%)
Use of injectable illicit drugs 0 (0.0%)
ndergone surgical procedures, and 205 (38%) had had some
ype of dental treatment. 120 (22%) reported to have a family
istory of hepatitis. 106 (20%) had had more than two sexual
artners. Only one individual reported using injectable illicit
rugs (Table 2).
40 patients (7.4%, 95% CI, 5.4% to 10%) were positive
or anti-HBc total. Five (0.92%, 95% CI, 0.3% to 2.3%) were
hronic carriers of the infection (HBsAg positive longer than
ix months), 31 (5.7%, 95% CI, 4.2% to 8.2%) were immune to
BV infection (positive anti-HBs), and four (0.8%, 95% CI, 0.2%
o 2.1%) had isolated total anti-HBc positive.
Comparing the differences between the characteristics of
roups with positive or negative anti-HBc it was observed that
nly the level of education and the presence of family history
f hepatitis were statistically associated with the presence of
positive marker (Table 3).
Despite the presence of anti-HBs marker, all anti-HBc pos-
tive and HBsAg negative samples (n=35) tested for HBV-DNA
ere negative. Thus, occult hepatitis B infection was not
bserved.
iscussion
epatitis B is a disease of signiﬁcant public health impact. Pre-
ention strategies are important for the effective control of
his infection, including universal vaccination and the use of
mmunoglobulin in certain situations. For this purpose, data
bout prevalence rates are needed, especially in populations
t risk for disease transmission, such as pregnant women.
No studies in the state of Maranhão on the prevalence
f serological markers of HBV in any population could be
etrieved. In this representative sample of pregnant women
ttending public services of São Luís, ﬁve patients had the
arker of current HBV infection (HBsAg) and thus, a preva-
ence rate of 0.94% (95% CI, 0.3% to 2.3%), which is not
ifferent from most of the results found in studies conducted
n other Brazilian states (ranging from 0.5% to 1.7%),8–11 and
ar below the prevalence found in a study in the state of Ama-
onas, which was as high as 8.7%.12 The prevalence found in
he present study conﬁrms the expectation that the state of
aranhão is a region of low HBV endemicity.
When comparing the characteristics of the groups withnd without positive markers for HBV, it was observed that
nly family history of hepatitis and low level of education
ere positively associated. Family history could be explained
y the possibility that some patients have family members17 (3.4%) 0.265
01 (0.3%) 0.926
with HBV infection, who could have transmitted the disease
to them and then cleared the virus (remaining the markers of
contact). Such occurrence is frequent after ﬁve years of age,
which is already clearly shown in some regions of the world,
including Brazil.20 Another explanation could be the possibil-
ity of episodes of acute infection in sexual partners, who may
have transmitted the disease, with subsequent progression to
cure. The level of education, probably a surrogate of low socio-
economic status, reﬂects poor knowledge about prevention as
well as poor access to health services, which lead to greater
susceptibility to infection.
Cases of occult hepatitis B among HBsAg negative and
anti-HBc positive individuals were not identiﬁed, even among
those who had isolated anti-HBc, without anti-HBs marker.
This result was consistent with the expectation that this
event is uncommon in areas of low endemicity, although
this has already been described in the general population in
Brazil.15
This study demonstrated the low prevalence of
chronic HBV infection in pregnant women assisted in
public maternity hospitals of São Luís. The presence
of serological markers for HBV infection was associ-
ated with lower educational levels and family history
of hepatitis. These results conﬁrm that investments in
education are important for the prevention of most dis-
eases. The absence of cases of occult HBV is consistent
with the area of low HBV prevalence expected for São
Luis.
Conﬂict of interest
All authors declare to have no conﬂict of interest.
Acknowledgements
We thank the National Council of Technological and Scien-
tiﬁc Development (CNPq) for the ﬁnancial support. We also
thank Prof. Dr. Natalino Salgado Filho and Bezelga Ana Luiza
Rodrigues for their indispensable contributions to the imple-
mentation of this study. They also thank the professionals of
all hospitals inwhichdata collectionwasperformed forhaving
promptly and openly received the researchers.












20. Brasil LM, Fonseca JCF, Souza RB, Braga WSM, Toledo LM.
Prevalência de marcadores para o vírus da hepatite B em520 braz j infect d
e f e r e n c e s
1. Hadziyannis SJ. Natural history of chronic hepatitis B in
Euro-Mediterranean and African Countries. J Hepatol.
2011;55:183–91.
2. Ott J, Stevens JA, Groeger J, Wiersma ST. Global epidemiology
of hepatitis B virus infection: new estimates of age-speciﬁc
HBsAg seroprevalence and endemicity. Vaccine.
2012;30:2212–9.
3. Paraná R, Almeida D. HBV epidemiology in Latin America.
Journal of Clinical Virol. 2005;34 Suppl 1:S130–3.
4. Pereira LMMB, Martelli CMT, Merchán-Hamann E, et al.
Population-based multicentric survey of hepatitis b infection
and risk factor differences among three regions in Brazil. Am
J Trop Med Hyg. 2009;81:240–7.
5. Margolis HS, Alter MJ, Hadler SC. Hepatitis B: evolving
epidemiology and implications for control. Seminars Liv Dis.
1991;11:84–92.
6. Mcmahon BJ. Natural history of chronic hepatitis B. Clinics in
Liver Dis. 2010;14:381–96.
7. Ni YH. Natural history of hepatitis B infection: pediatric
perspective. J Gastroenterol. 2011;46:1–8.
8. Duarte G, Mussi-Pinhata M, Martinez R, Lemos C, Figueiredo
EML, Quintana SM. Freqüência de gestantes portadoras do
HBsAg em uma comunidade brasileira. Bol Oﬁc Sanit
Panameric. 1996;120:189–97.
9. Perim EB, Passos ADC. Hepatite B em gestantes atendidas
pelo Programa do Pré-Natal da Secretaria Municipal de Saúde
de Ribeirão Preto, Brasil: prevalência da infecc¸ão e cuidados
prestados aos recém-nascidos. Rev Bras Epidemiol.
2005;8:272–81.0. Bertolini DA, Pinho JRR, Saraceni CP, Moreira RC, Granato CFH,
Carrilho FJ. Prevalence of serological markers of hepatitis B in
pregnant women from Parana State, Brazil. Braz J Med Biolog
Res. 2006;39:1083–90.12;16(6):517–520
1. Liell AP, Weber D, Toscan C, Fornari F, Madalosso LF.
Prevalência do HBsAg em gestantes de Passo Fundo, RS,
estudo comparativo de saúde público e privado. Arq
Gastroenterol. 2009;46:75–7.
2. Kiesslich D, Fraigi NA, Crispim MA, et al. Prevalência de
marcadores sorológicos e moleculares do vírus da hepatite B
em gestantes do Estado do Amazonas. Epidemio Serv Saude.
2003;12:155–64.
3. Said ZNA. An overview of occult hepatitis B virus infection.
World J Gastroenterol. 2011;17:1927–38.
4. Gerlich WH, Bremer C, Saniewski M, et al. Occult hepatitis B
virus infection: detection and signiﬁcance. Dig Dis.
2010;28:116–25.
5. Almeida D, Tavares-Neto J, Trepo C, et al. Occult HBV
infection in the Brazilian Northeastern region: a preliminary
report. Braz J Infect Dis. 2008;12:310–2.
6. Motta JS, Mello FC, Lago BV, Perez RM, Gomes SA, Figueiredo
FF. Occult hepatitis B virus infection and lamivudine-resistant
mutations in isolates from renal patients undergoing
hemodialysis. J Gastroenterol Hepatol. 2010;25:
101–6.
7. Kwon CI, Hwang SG, Shin SJ, et al. Occult hepatitis B virus
infection in pregnant woman and its clinical Implication. Liv
Inter. 2008;28:667–74.
8. Tabor E. Infections by hepatitis B surface antigen gene
mutants in Europe and North America. J Med Virol.
2006;78(Supp 1):S43–7.
9. Sitnik R, Pinho JRR, Bertolini DA, Bernadini AP, Da Silva LC,
Carrilho FJ. Hepatitis B virus genotypes and precore and core
mutants in Brazilian patients. J Clin Microbiol.
2004;42:2455–60.contatos domiciliares no Estado do Amazonas. Rev Soc Bras
Med Trop. 2003;36:565–70.
